Recent Updates
Recently added Catalysts
RIGL Positive Sentiment Score: 75/100

Rigel to Present at the 2023 Cantor Global Healthcare Conference

Wednesday, September 20, 2023 1 min read
Key Takeaway: Rigel Pharmaceuticals, Inc. has announced that its chief financial officer, Dean Schorno, will present a company overview at the Cantor Global Healthcare Conference on September 27, 2023. This event will be held in New York City and will provide investors with insights into Rigel's operations and strategies. The conference presentation is part of Rigel's efforts to enhance its communication with investors and share developments regarding its therapies for hematologic disorders and cancer.

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel Pharmaceuticals is actively engaging investors by presenting at a major healthcare conference.
  • The presentation indicates a commitment to transparency and communication with stakeholders.
  • The company's focus on novel therapies suggests potential growth and innovation in the biopharma sector.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Sept. 20, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, will present a company overview at the Cantor Global Healthcare Conference on Wednesday, September 27, 2023 at 3:35 p.m. ET in New York, NY.
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Investors & Media Contacts:
Rigel Pharmaceuticals, Inc.
Email: [email protected]
SOURCE Rigel Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Rigel Pharmaceuticals present at the conference?

Rigel Pharmaceuticals will present on September 27, 2023, at 3:35 p.m. ET.

Where can I access the webcast of the presentation?

The live webcast can be accessed on Rigel's Investor Relations webpage.

What does Rigel Pharmaceuticals specialize in?

Rigel is focused on developing therapies for hematologic disorders and cancer.

When was Rigel Pharmaceuticals founded?

Rigel Pharmaceuticals was founded in 1996.

Where is Rigel Pharmaceuticals located?

Rigel Pharmaceuticals is based in South San Francisco, California.

Tags: RIGL Viatris Investor Conferences Healthcare Rigel Pharmaceuticals Cantor Global Healthcare Conference biotechnology hematologic disorders cancer
Last updated: Sep 20, 2023